Platform & Pipeline

BiomeBank's multi-disciplinary team of drug development experts are developing live biotherapeutic products to treat disease.


BiomeBank Discovery Platform

The BiomeBank team have developed a platform which combines unique microbiology and bioinformatics capabilities for discovery of microbial biomarkers, leads, and targets.

Unique Culturing Capabilities

Proprietary methods to culture strict anaerobic microbes from patient samples. This underpins the discovery team's ability to identify specific microbial strains associated with patient outcomes.

Bioinformatics and Machine Learning

A pipeline of bioinformatic and machine learning methods linked with culturing capabilities allows the discovery team to understand which microbial strains in a complex community contribute to health.


BiomeBank has a pipeline of drug development programs in multiple indications underpinned by a world leading microbiome drug discovery platform.